SCHEMBL5701136

SCHEMBL5701136

c1ccc2cc(OCCCCNC3CCCCC3)ccc2c1

nearest known ligand 0.56

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 5/20 0.56
ALDH1A1 P00352 3/20 0.54
HRH3 Q9Y5N1 7/20 0.52
KMT2A Q03164 2/20 0.52
MEN1 O00255 1/20 0.52
SMN1; SMN2 Q16637 1/20 0.52
CYP1A2 P05177 1/20 0.50
CYP2D6 P10635 1/20 0.50
CYP2C19 P33261 1/20 0.50
FAAH O00519 1/20 0.49
EPHX1 P07099 1/20 0.49
XDH P47989 1/20 0.48
FOXM1 Q08050 1/20 0.48
MAPK1 P28482 1/20 0.47
TDP1 Q9NUW8 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5701158 0.96 KDM4E (0.61) KDM4EALDH1A1HRH3KMT2AMEN1
SCHEMBL5701229 0.92 KDM4E (0.60) KDM4EALDH1A1KMT2AMEN1SMN1; SMN2
SCHEMBL23074698 0.79 ALDH1A1 (0.70) KDM4EALDH1A1KMT2AMEN1SMN1; SMN2
SCHEMBL12204135 0.79 ALDH1A1 (0.70) KDM4EALDH1A1KMT2AMEN1SMN1; SMN2
SCHEMBL7374425 0.78 KDM4E (0.77) KDM4EALDH1A1KMT2AMEN1SMN1; SMN2
Hydrochloric Acid SCHEMBL7372091 0.77 KDM4E (0.76) KDM4EALDH1A1KMT2AMEN1SMN1; SMN2
SCHEMBL29045834 0.77 KDM4E (0.79) KDM4EALDH1A1KMT2AMEN1SMN1; SMN2
SCHEMBL8565990 0.76 TDP1 (0.76) KDM4EHRH3SMN1; SMN2MAPK1TDP1
SCHEMBL5701202 0.75 HRH3 (0.63) KDM4EHRH3MAPK1TDP1
SCHEMBL12204181 0.75 XDH (0.60) KDM4EALDH1A1KMT2AMEN1SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1682484-A1 OMEGA-SUBSTITUTED-NAPHTHYLOXYALKLAMINO DERIVATIVES AS ANTIHYPERGLYCEMIC AGENTS AND PREPARATION COUNCIL OF SCIENTIFIC AND INDUSTRIAL RESEARCH (IN) 2006-07-26 EP claimed
US-7081465-B2 Alpha-substituted naphthyloxy omega-substituted alky/aryl amino-substituted alkane derivatives as agent for treatment or prophylaxis of diabetes and related metabolic disorders COUNCIL OF SCIENTIFIC AND INDUSTRIAL RESEARCH (IN) 2006-07-25 US claimed
WO-2005042465-A1 OMEGA-SUBSTITUTED-NAPHTHYLOXYALKLAMINO DERIVATIVES AS ANTIHYPERGLYCEMIC AGENTS AND PREPARATION COUNCIL OF SCIENTIFIC AND INDUSTRIAL RESEARCH (IN) 2005-05-12 WO claimed
EP-1682484-A1 OMEGA-SUBSTITUTED-NAPHTHYLOXYALKLAMINO DERIVATIVES AS ANTIHYPERGLYCEMIC AGENTS AND PREPARATION COUNCIL OF SCIENTIFIC AND INDUSTRIAL RESEARCH (IN) 2006-07-26 EP disclosed
WO-2005042465-A1 OMEGA-SUBSTITUTED-NAPHTHYLOXYALKLAMINO DERIVATIVES AS ANTIHYPERGLYCEMIC AGENTS AND PREPARATION COUNCIL OF SCIENTIFIC AND INDUSTRIAL RESEARCH (IN) 2005-05-12 WO disclosed